Featured publications
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
November 2, 2023 | The New England Journal of Medicine
Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development
April 5, 2023 | Frontiers in Molecular Biosciences
Quantifying the nativeness of antibody sequences using long short-term memory networks
December 31, 2019 | Protein Engineering, Design, and Selection
Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development
April 5, 2023 | Frontiers in Molecular Biosciences
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
May 10, 2022 | Kidney International Reports
Modeling cell-specific dynamics and regulation of the common gamma chain cytokines
April 27, 2021 | Cell Reports
Characterization of an Antibody Recognizing the Conserved Inner Core of Pseudomonas aeruginosa Lipopolysaccharides
November 3, 2020 | Biochemistry
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo
November 2, 2020 | Blood Cancer Journal
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study
March 7, 2020 | Antiviral Research
Quantifying the nativeness of antibody sequences using long short-term memory networks
December 31, 2019 | Protein Engineering, Design, and Selection
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
March 16, 2019 | Kidney International
Structural prediction of antibody-APRIL complexes by computational docking constrained by antigen saturation mutagenesis library data
February 13, 2019 | Journal of Molecular Recognition
Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study
January 9, 2019 | EBioMedicine
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »